Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes

Abstract: Introduction and aims. Cholangiocarcinomas are a heterogeneous group of tumors that can be classified into three clinically distinct types of cancers, intrahepatic, perihilar and distal cholangiocarcinoma. The inconsistent use of nomenclature for these cancers has obscured a true knowledge of the epidemiology, natural history and response to therapy of these cancers. Our aims were to define demographic characteristics, management and outcomes of these three distinct cancer types. Materials and methods. A retrospective study of patients enrolled in an institutional cancer registry from 1992 to 2010. Median survival was compared between different treatment modalities over three time periods for the three types of cholangiocarcinoma at different stages of the disease using Kaplan Meyer analysis. Results. 242 patients were identified. All cases were reviewed and classified into intrahepatic (90 patients), distal (48 patients) or perihilar (104 patients) cholangiocarcinomas. These cancers differed in median age of onset, gender distribution, median survival and stage. 13.8% of patients presented with stage I, 5.8% with stage II, 9.6% with stage III, 28% with stage IV, with 41.8% having unknown stage. The overall median survival was 15.8 months, and was 23, 25, 14, and 4.5 months for stages I, II, III, and IV respectively. Surgery improved survival in both early and advanced stages. Multimodality therapies further improved outcomes, particularly for perihilar cholangiocarcinoma. Conclusion. Perihilar, distal and intrahepatic cholangiocarcinoma vary in their presentation, natural history and therapeutic approach to management. A consistently applied classification is essential for meaningful interpretation of studies of these cancers.

Saved in:
Bibliographic Details
Main Authors: Waseem,David, Tushar,Patel
Format: Digital revista
Language:English
Published: Asociación Mexicana de Hepatología A.C. 2017
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-26812017000100133
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1665-26812017000100133
record_format ojs
spelling oai:scielo:S1665-268120170001001332017-06-02Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and OutcomesWaseem,DavidTushar,Patel Biliary cancers Natural history Management Survival Abstract: Introduction and aims. Cholangiocarcinomas are a heterogeneous group of tumors that can be classified into three clinically distinct types of cancers, intrahepatic, perihilar and distal cholangiocarcinoma. The inconsistent use of nomenclature for these cancers has obscured a true knowledge of the epidemiology, natural history and response to therapy of these cancers. Our aims were to define demographic characteristics, management and outcomes of these three distinct cancer types. Materials and methods. A retrospective study of patients enrolled in an institutional cancer registry from 1992 to 2010. Median survival was compared between different treatment modalities over three time periods for the three types of cholangiocarcinoma at different stages of the disease using Kaplan Meyer analysis. Results. 242 patients were identified. All cases were reviewed and classified into intrahepatic (90 patients), distal (48 patients) or perihilar (104 patients) cholangiocarcinomas. These cancers differed in median age of onset, gender distribution, median survival and stage. 13.8% of patients presented with stage I, 5.8% with stage II, 9.6% with stage III, 28% with stage IV, with 41.8% having unknown stage. The overall median survival was 15.8 months, and was 23, 25, 14, and 4.5 months for stages I, II, III, and IV respectively. Surgery improved survival in both early and advanced stages. Multimodality therapies further improved outcomes, particularly for perihilar cholangiocarcinoma. Conclusion. Perihilar, distal and intrahepatic cholangiocarcinoma vary in their presentation, natural history and therapeutic approach to management. A consistently applied classification is essential for meaningful interpretation of studies of these cancers.info:eu-repo/semantics/openAccessAsociación Mexicana de Hepatología A.C.Annals of Hepatology v.16 n.1 20172017-02-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-26812017000100133en10.5604/16652681.1226927
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Waseem,David
Tushar,Patel
spellingShingle Waseem,David
Tushar,Patel
Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
author_facet Waseem,David
Tushar,Patel
author_sort Waseem,David
title Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
title_short Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
title_full Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
title_fullStr Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
title_full_unstemmed Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes
title_sort intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes
description Abstract: Introduction and aims. Cholangiocarcinomas are a heterogeneous group of tumors that can be classified into three clinically distinct types of cancers, intrahepatic, perihilar and distal cholangiocarcinoma. The inconsistent use of nomenclature for these cancers has obscured a true knowledge of the epidemiology, natural history and response to therapy of these cancers. Our aims were to define demographic characteristics, management and outcomes of these three distinct cancer types. Materials and methods. A retrospective study of patients enrolled in an institutional cancer registry from 1992 to 2010. Median survival was compared between different treatment modalities over three time periods for the three types of cholangiocarcinoma at different stages of the disease using Kaplan Meyer analysis. Results. 242 patients were identified. All cases were reviewed and classified into intrahepatic (90 patients), distal (48 patients) or perihilar (104 patients) cholangiocarcinomas. These cancers differed in median age of onset, gender distribution, median survival and stage. 13.8% of patients presented with stage I, 5.8% with stage II, 9.6% with stage III, 28% with stage IV, with 41.8% having unknown stage. The overall median survival was 15.8 months, and was 23, 25, 14, and 4.5 months for stages I, II, III, and IV respectively. Surgery improved survival in both early and advanced stages. Multimodality therapies further improved outcomes, particularly for perihilar cholangiocarcinoma. Conclusion. Perihilar, distal and intrahepatic cholangiocarcinoma vary in their presentation, natural history and therapeutic approach to management. A consistently applied classification is essential for meaningful interpretation of studies of these cancers.
publisher Asociación Mexicana de Hepatología A.C.
publishDate 2017
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-26812017000100133
work_keys_str_mv AT waseemdavid intrahepaticperihilaranddistalcholangiocarcinomamanagementandoutcomes
AT tusharpatel intrahepaticperihilaranddistalcholangiocarcinomamanagementandoutcomes
_version_ 1756227379424919552